Detalles de la búsqueda
1.
Real-world osimertinib for EGFR mutation-positive non-small-cell lung cancer with acquired T790M mutation.
Future Oncol
; 16(21): 1537-1547, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32662665
2.
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: Multicenter, single-arm, phase 2 trial (ABC Study).
Cancer
; 124(19): 3830-3838, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30192383
3.
The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
J Infect Chemother
; 24(5): 353-357, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29361415
4.
[THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].
Kekkaku
; 90(8): 619-23, 2015 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-26665518
5.
[Safe treatment of lung squamous cell carcinoma with nanoparticle albumin-bound Paclitaxel in a patient with a previous hypersensitivity reaction after docetaxel administration].
Gan To Kagaku Ryoho
; 42(3): 375-7, 2015 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-25812512
6.
Impact of serum eicosapentaenoic acid/arachidonic acid ratio on overall survival in lung cancer patients treated with pembrolizumab: a pilot study.
Sci Rep
; 14(1): 1384, 2024 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38228757
7.
Pulmonary disease caused by rapidly growing mycobacteria: a retrospective study of 44 cases in Japan.
Respiration
; 85(4): 305-11, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-22890130
8.
Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial.
Clin Lung Cancer
; 24(6): 519-527.e4, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37344331
9.
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.
Sci Adv
; 9(20): eade0718, 2023 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37205755
10.
Non-small cell lung cancer with tumor proportion score > 90% could increase the risk of severe immune-related adverse events in first-line treatments with immune checkpoint inhibitors: A retrospective single-center study.
Thorac Cancer
; 13(17): 2450-2458, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35820673
11.
Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients.
Sci Rep
; 12(1): 17461, 2022 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261600
12.
Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L).
Lung Cancer
; 168: 38-45, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477147
13.
A case of acute and severe thrombocytopenia due to readministration of rifampicin.
J Infect Chemother
; 17(2): 288-90, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20827562
14.
Bronchial ethanol injection therapy for airway obstruction in lung cancer patients.
Respirol Case Rep
; 9(9): e0816, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34354837
15.
EGFR-mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib.
Thorac Cancer
; 12(9): 1441-1444, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682361
16.
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report.
Thorac Cancer
; 12(12): 1935-1939, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33973724
17.
Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens.
Mod Rheumatol
; 20(2): 130-3, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19898919
18.
Radiographic change over 11 years in a patient with asbestos-related pleural disease.
Respirol Case Rep
; 8(7): e00642, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32832086
19.
Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
Thorac Cancer
; 11(11): 3317-3325, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32986306
20.
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune-related adverse effect: A case report.
Thorac Cancer
; 10(5): 1276-1279, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30964601